Neshima Medical

Life-saving Treatments for Severe Respiratory Diseases

Health Tech & Life Sciences
Active
Seed Haifa, Israel Founded 2020
Last updated 2026-06-18
Total raised
Last: 2025-12
Stage
Seed
Founded
2020
Headcount
6
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

Neshima is developing life-saving treatments for severe lung diseases using LiFT™, a patented foam-based delivery platform. LiFT™ enables deep and uniform therapeutic delivery to the alveoli, overcoming the limitations of inhalers, nebulizers, and intravenous treatments. Our lead applications include a regenerative cell therapy for COPD. As a cost-effective PoC we are also developing an ICU-delivered antibiotic treatment for antimicrobial-resistant infections. A fully functional prototype has been tested in large animals. Neshima is targeting a $10 billion U.S. market with a B2B model.

Funding history · 2 rounds · — total

2025-12
Undisclosed
2023-03
Grant Undisclosed

Q&A

What is Neshima Medical's primary focus?
Neshima Medical is developing life-saving treatments for severe lung diseases using its patented LiFT™ foam-based delivery platform.
When was Neshima Medical founded?
Neshima Medical was founded in April 2020.
How many employees does Neshima Medical currently have?
Neshima Medical has 1-10 employees.
What is Neshima Medical's lead application for its LiFT™ platform?
Neshima Medical's lead application for the LiFT™ platform is a regenerative cell therapy for COPD.
Has Neshima Medical received any grant funding?
Yes, Neshima Medical received a grant from the Israel Innovation Authority in March 2023.
Which investor participated in Neshima Medical's funding round in December 2025?
embARC Ventures participated in Neshima Medical's funding round in December 2025.
What is the estimated market Neshima Medical is targeting?
Neshima Medical is targeting a $10 billion U.S. market with a B2B model.
Who are the co-founders of Neshima Medical?
The co-founders of Neshima Medical are Yan Ostrovski (Co-founder & CEO), Ramy Fishler (Co-founder & CTO), Avital Frenkel (Co-founder & Chief Systems Architect), and Josué Sznitman (Co-founder & Chief Scientific Officer).

Team · 4

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗
Founder · Co-founder & Chief Systems Architect
LinkedIn ↗
Founder · Co-founder & Chief scientific officer
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

patientsmedical-devicesrespiratoryhealthcare-providershospitalsmedical-technologiesdrug-deliverypatent-pending
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)